464 related articles for article (PubMed ID: 2354458)
1. Chromosome aberrations in uterine smooth muscle tumors: potential diagnostic relevance of cytogenetic instability.
Fletcher JA; Morton CC; Pavelka K; Lage JM
Cancer Res; 1990 Jul; 50(13):4092-7. PubMed ID: 2354458
[TBL] [Abstract][Full Text] [Related]
2. Pathology, cytogenetics and molecular biology of uterine leiomyomas and other smooth muscle lesions.
Quade BJ
Curr Opin Obstet Gynecol; 1995 Feb; 7(1):35-42. PubMed ID: 7742513
[TBL] [Abstract][Full Text] [Related]
3. Molecular pathogenesis of uterine smooth muscle tumors from transcriptional profiling.
Quade BJ; Wang TY; Sornberger K; Dal Cin P; Mutter GL; Morton CC
Genes Chromosomes Cancer; 2004 Jun; 40(2):97-108. PubMed ID: 15101043
[TBL] [Abstract][Full Text] [Related]
4. ["Benign metastasizing leiomyoma"? A case report without evidence for unbalanced cytogenetic aberrations].
Tietze L; Günther K; Merkelbach-Bruse S; Handt S
Verh Dtsch Ges Pathol; 1998; 82():332-5. PubMed ID: 10095455
[TBL] [Abstract][Full Text] [Related]
5. Bcl-2 receptor expression in patients with uterine smooth muscle tumors: an immunohistochemical analysis comparing leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma.
Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Mayerhofer K
J Soc Gynecol Investig; 2004 Apr; 11(3):187-91. PubMed ID: 15051039
[TBL] [Abstract][Full Text] [Related]
6. Distinctive cytogenetic profile in benign metastasizing leiomyoma: pathogenetic implications.
Nucci MR; Drapkin R; Dal Cin P; Fletcher CD; Fletcher JA
Am J Surg Pathol; 2007 May; 31(5):737-43. PubMed ID: 17460458
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of the c-myc proto-oncogene occurs frequently in uterine sarcomas.
Jeffers MD; Richmond JA; Macaulay EM
Mod Pathol; 1995 Sep; 8(7):701-4. PubMed ID: 8539225
[TBL] [Abstract][Full Text] [Related]
8. Analysis of genetic alterations in uterine leiomyomas and leiomyosarcomas by comparative genomic hybridization.
Packenham JP; du Manoir S; Schrock E; Risinger JI; Dixon D; Denz DN; Evans JA; Berchuck A; Barrett JC; Devereux TR; Ried T
Mol Carcinog; 1997 Aug; 19(4):273-9. PubMed ID: 9290705
[TBL] [Abstract][Full Text] [Related]
9. Use of X-chromosome inactivation pattern to determine the clonal origins of uterine leiomyoma and leiomyosarcoma.
Zhang P; Zhang C; Hao J; Sung CJ; Quddus MR; Steinhoff MM; Lawrence WD
Hum Pathol; 2006 Oct; 37(10):1350-6. PubMed ID: 16949924
[TBL] [Abstract][Full Text] [Related]
10. Frequent loss of heterozygosity for chromosome 10 in uterine leiomyosarcoma in contrast to leiomyoma.
Quade BJ; Pinto AP; Howard DR; Peters WA; Crum CP
Am J Pathol; 1999 Mar; 154(3):945-50. PubMed ID: 10079273
[TBL] [Abstract][Full Text] [Related]
11. Uterine leiomyomas: cytogenetic and histologic profile.
Meloni AM; Surti U; Contento AM; Davare J; Sandberg AA
Obstet Gynecol; 1992 Aug; 80(2):209-17. PubMed ID: 1635734
[TBL] [Abstract][Full Text] [Related]
12. Uterine smooth-muscle tumor of uncertain malignant potential metastasizing to the humerus as a high-grade leiomyosarcoma.
Shapiro A; Ferenczy A; Turcotte R; Bruchim I; Gotlieb WH
Gynecol Oncol; 2004 Sep; 94(3):818-20. PubMed ID: 15350379
[TBL] [Abstract][Full Text] [Related]
13. Exploring chromosomal abnormalities and genetic changes in uterine smooth muscle tumors.
Liegl-Atzwanger B; Heitzer E; Flicker K; Müller S; Ulz P; Saglam O; Tavassoli F; Devouassoux-Shisheboran M; Geigl J; Moinfar F
Mod Pathol; 2016 Oct; 29(10):1262-77. PubMed ID: 27363490
[TBL] [Abstract][Full Text] [Related]
14. MED12 exon 2 mutations in uterine and extrauterine smooth muscle tumors.
Schwetye KE; Pfeifer JD; Duncavage EJ
Hum Pathol; 2014 Jan; 45(1):65-70. PubMed ID: 24196187
[TBL] [Abstract][Full Text] [Related]
15. Recurrent chromosomal aberrations in intravenous leiomyomatosis of the uterus: high-resolution array comparative genomic hybridization study.
Buza N; Xu F; Wu W; Carr RJ; Li P; Hui P
Hum Pathol; 2014 Sep; 45(9):1885-92. PubMed ID: 25033729
[TBL] [Abstract][Full Text] [Related]
16. Morphologic features of prognostic significance in uterine smooth muscle tumors: a review of eighty-four cases.
Burns B; Curry RH; Bell ME
Am J Obstet Gynecol; 1979 Sep; 135(1):109-14. PubMed ID: 474641
[TBL] [Abstract][Full Text] [Related]
17. Expression of the O-linked N-acetylglucosamine containing epitope H in normal myometrium and uterine smooth muscle cell tumors.
Sgantzos MN; Galani V; Arvanitis LD; Charchanti A; Psathas P; Nakou M; Havaki S; Kallioras V; Marinos E; Vamvakopoulos NC; Kittas C
Pathol Res Pract; 2007; 203(1):31-7. PubMed ID: 17129677
[TBL] [Abstract][Full Text] [Related]
18. Different characteristics of mitochondrial microsatellite instability between uterine leiomyomas and leiomyosarcomas.
Lee JH; Ryu TY; Cho CH; Kim DK
Pathol Oncol Res; 2011 Jun; 17(2):201-5. PubMed ID: 20853077
[TBL] [Abstract][Full Text] [Related]
19. Cytogenetics of multiple uterine leiomyomas, parametrial leiomyoma and disseminated peritoneal leiomyomatosis.
Mark J; Havel G; Dahlenfors R; Wedell B
Anticancer Res; 1991; 11(1):33-9. PubMed ID: 2018368
[TBL] [Abstract][Full Text] [Related]
20. Detection of chromosomal abnormalities of chromosome 12 in uterine leiomyoma using fluorescence in situ hybridization.
Hayashi S; Miharu N; Okamoto E; Samura O; Hara T; Ohama K
Jpn J Hum Genet; 1996 Mar; 41(1):193-202. PubMed ID: 8914635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]